Abstract
Do patients with ischemic cardiomyopathy benefit from surgical revascularization? This question has been studied extensively over the last 20–30 years and needs to be analyzed from different viewpoints. What is the evidence concerning surgical revascularization of patients with an ejection fraction of 35%? What is the role of percutaneous coronary interventions (PCI) and optimal medical therapy (OMT). What do the guidelines tell us? And are current strategies still timely in view of new developments in the field of end-stage heart failure?
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Velazquez E, Lee L, Jones R, Al-Khalidi H, Hill J, Panza J, et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374(16):1511–20.
Aldermann EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983;68:785–95.
The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the veterans administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med. 1984;311:1333–9.
Varnauskas E, the European Coronary Surgery Study Group. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med. 1988;319:332–7.
Velazquez E, Lee K, Deja M, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364(17):1607–16.
Elamm C, Fang J. The world post-STITCH: is this a “game changer?” A non-invasive cardiologist’s perspective – revascularisation is the treatment of choice only in patients who fail medical therapy. Prog Cardiovasc Dis. 2013;55:466–9.
Hochman J, Lamas G, Buller C, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355:2395–407.
Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–16.
Hochmann J, Reynolds H, Dzavik V, et al. Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction. Circulation. 2011;124(21):2320–8.
Sedlis S, Hartigan P, Teo K, et al. Effect of PCI on long-term survival in patients with stable ischemic heart disease. N Engl J Med. 2015;373(20):1937–46.
Cleland JG, Calvert M, Freemantle N, et al. The heart failure revascularization trial (HEART). Eur J Heart Fail. 2011;13:227–33.
Cleland JG, Pennell DJ, Ray SG, Coats AJ, Macfarlane PW, Murray GD, et al. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomized controlled trial. Lancet. 2003;362:14–21.
Kunadian V, Pugh A, Zaman AG, Qiu W. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies. Coron Artery Dis. 2012;23:469–79.
Marui A, Kimura T, Nishiwaki N, et al. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol. 2014;114:988–96.
Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, Higgins RS, Carlson RE, Jones RH. Drug-eluting stents vs. coronary artery bypass grafting in multivessel coronary disease. N Engl J Med. 2008;358:331–41.
Hlatky MA, Boothroyd DB, Baker L, Kazi DS, Solomon MD, Chang TI, Shilane D, Go AS. Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention a cohort study. Ann Intern Med. 2013;158:727–35.
Nagendran J, Norris CM, Graham MM, Ross DB, Macarthur RG, Kieser TM, Maitland AM, Southern D, Meyer SR. Coronary revascularization for patients with severe left ventricular dysfunction. Ann Thorac Surg. 2013;96:2038–44.
Hlatky M, Boothroyd D, Bravata D, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009;373:1190–7.
Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, Jeong DS, Sung K, Kim WS, Lee YT, Gwon HC. Long-term outcomes of drug-eluting stent implantation versus coronary artery bypass grafting for patients with coronary artery disease and chronic left ventricular systolic dysfunction. Am J Cardiol. 2013;112:623–9.
Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011;124(23):e652–735.
Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2014;35:2541–619.
Yancy CW, Jessup M, Bozkurt B, et al. 2013ACCF/AHAguideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240–327.
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200.
Estep J, Starling R, Horstmanshof D. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP study. J Am Coll Cardiol. 2015;66:1747–61.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Reineke, D., Carrel, T. (2019). Myocardial Revascularization in Patients with Left Ventricular Dysfunction. In: Feldman, D., Mohacsi, P. (eds) Heart Failure. Cardiovascular Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-98184-0_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-98184-0_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98182-6
Online ISBN: 978-3-319-98184-0
eBook Packages: MedicineMedicine (R0)